Data di Pubblicazione:
2022
Abstract:
Deferoxamine (DFO) is a siderophore widely studied for its ability to bind iron(III) strongly. Thanks to its versatility, it is suitable for several clinical and analytical applications, from the recognized iron(III) chelation therapy to the most recent applications in sensing. The presence of three hydroxamic functional groups enables Deferoxamine to form stable complexes with iron(III) and other divalent and trivalent metal ions. Moreover, the terminal amino group in the DFO molecule, not involved in metal ion complexation, allows modification or functionalization of solid phases, nanoobjects, biopolymers, electrodes and optical devices. This review summarizes and discusses deferoxamine-based applications for the chelation and recognition of Fe(III).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
deferoxamine; DFO; iron(III); iron(III) chelators; deferoxamine-based polymers; deferoxamine-based sensors; deferoxamine-modified electrodes; deferoxamine-functionalized nanoparticles; drug delivery; analytical chemistry; metal-ions sensing
Elenco autori:
Alberti, G; Zanoni, C; Magnaghi, Lr; Biesuz, R
Link alla scheda completa:
Pubblicato in: